Stephen Richard
CIK: 0001823843
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ANIK
Anika Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Richard Stephen
Richard Stephen (SEC CIK 0001823843) files insider reports with the SEC as Director of Anika Therapeutics, Inc. (ANIK).
Signal8 holds 2 ownership filings by Richard Stephen, all Form 4s, filed between Jun 24, 2025 and Jun 23, 2026. Those filings report 2 transactions, from Jun 20, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Richard Stephen's filings is in BEDFORD, MA.
Recent filings by Richard Stephen
Other insiders filing for Anika Therapeutics, Inc. (ANIK)
- Fischetti Gary P, Director
- HENNEMAN JOHN B III, Director
- Capper Joseph H, Director
- CONLEY SHERYL L, Director
- Griffin Stephen D., President and CEO
- McLeod Ian, SVP, CAO & Treasurer